Trial Profile
A Phase IIb Clincal Trial Treating Patients with Advanced Palpable Solid Tumor After Failure From Conventional Treatments and Patients Who are Suitable for Palliative Treatments with PTS(para-toluenesulfonamide injection), A Novel Local Invasive Anticancer Drug, by Intratumoral Injection Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs P-toluenesulfonamide (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 22 Jan 2013 New trial record